INLURIYO vs KANJINTI
Independent side-by-side comparison.
Possible drug interaction. INLURIYO and KANJINTI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.
Rating
New
72/100
Pharmacy pays
—
—
Type
RX
RX
Active ingredient
IMLUNESTRANT TOSYLATE
TRASTUZUMAB-ANNS
Manufacturer
Dosage forms
Tablet
Injectable
Drug class
—
—
Boxed warning
None
Treats
Breast Neoplasms
Breast Neoplasms, Gastrointestinal Neoplasms
Frequently asked questions
What is the difference between Inluriyo and Kanjinti?
Inluriyo contains Imlunestrant Tosylate, while Kanjinti contains Trastuzumab-Anns — they have different active ingredients.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.